Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...
In the tough market conditions last year, investors and big pharma companies were more likely to place their bets on later, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback